Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01770418 · ClinicalTrials.gov registry record · Phase 1
A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
A Phase 1 study of Lung Neoplasms, sponsored by Proton Collaborative Group.
- Active
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
- 6
- Study locations
NCT01770418: Active Phase 1 study of Lung Neoplasms, sponsored by Proton Collaborative Group.
NCT01770418 is a Phase 1 study of Lung Neoplasms that is active but no longer recruiting, run by Proton Collaborative Group. The registered enrollment target is 32 participants, below the 465-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (93% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01770418, a Phase 1 study of Lung Neoplasms, is active but no longer recruiting, sponsored by Proton Collaborative Group.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this research study is to compare the effects (good and bad) on subjects and their cancer using standard chemotherapy in combination with hypofractionated proton radiation therapy. Hypofractionation is a technique that delivers higher daily doses of radiation over a shorter period of time.
Primary Outcome
This phase will have a minimum of 2 treated patients and we anticipate that the MTD will be located before a maximum of 28 patients are treated. The trial begins by treating 5 patients at 2.5 Gy (RBE)/fraction to a dose of 60 Gy (RBE).
Conditions Studied
Interventions
- RADIATION Radiation with Concurrent Chemotherapy
Study Locations (6)
Florida
- University of Florida Proton Therapy Institute - Jacksonville
Illinois
- Northwestern Medicine Chicago Proton Center - Warrenville
Maryland
- Maryland Proton Treatment Center - Baltimore
New Jersey
- Princeton ProCure Management LLC - Somerset
Oklahoma
- Oklahoma Proton Center - Oklahoma City
Virginia
- Hampton University Proton Therapy Institute - Hampton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-03 |
| Phase | Phase 1 |
What the registry record for NCT01770418 still lists
NCT01770418 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 465-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Lung Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Radiation with Concurrent Chemotherapy is the first listed.
NCT01770418 lists 6 locations in 6 states (Florida, Illinois, Maryland).
Frequently Asked Questions
What is clinical trial NCT01770418 about?
NCT01770418 is a clinical study titled "A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer". The purpose of this research study is to compare the effects (good and bad) on subjects and their cancer using standard chemotherapy in combination with hypofractionated proton radiation therapy. Hypofractionation is a technique that delivers higher daily doses of radiation over a shorter period of ...
What is the current status of trial NCT01770418?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2013-03.
What conditions does trial NCT01770418 study?
This clinical trial studies the following conditions: Lung Neoplasms.
What interventions are being tested in trial NCT01770418?
The interventions under investigation include: Radiation with Concurrent Chemotherapy (RADIATION).
Who is sponsoring clinical trial NCT01770418?
This trial is sponsored by Proton Collaborative Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01770418 being conducted?
This trial has 6 study locations across Florida, Illinois, Maryland, New Jersey, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01770418's enrollment target sits among peer trials
32 18th of 22 higher than 5 of 22 other Lung Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RECRUITING · Phase 1
-
A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors
ACTIVE NOT RECRUITING · Phase 1
-
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
COMPLETED · Phase 1
-
Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases
COMPLETED · Phase 1
-
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
COMPLETED · Phase 1
-
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia